- Open Access
Use of T2-weighted magnetic resonance imaging of the optic nerve sheath to detect raised intracranial pressure
Critical Care volume 12, Article number: R114 (2008)
The dural sheath surrounding the optic nerve communicates with the subarachnoid space, and distends when intracranial pressure is elevated. Magnetic resonance imaging (MRI) is often performed in patients at risk for raised intracranial pressure (ICP) and can be used to measure precisely the diameter of optic nerve and its sheath. The objective of this study was to assess the relationship between optic nerve sheath diameter (ONSD), as measured using MRI, and ICP.
We conducted a retrospective blinded analysis of brain MRI images in a prospective cohort of 38 patients requiring ICP monitoring after severe traumatic brain injury (TBI), and in 36 healthy volunteers. ONSD was measured on T2-weighted turbo spin-echo fat-suppressed sequence obtained at 3 Tesla MRI. ICP was measured invasively during the MRI scan via a parenchymal sensor in the TBI patients.
Measurement of ONSD was possible in 95% of cases. The ONSD was significantly greater in TBI patients with raised ICP (>20 mmHg; 6.31 ± 0.50 mm, 19 measures) than in those with ICP of 20 mmHg or less (5.29 ± 0.48 mm, 26 measures; P < 0.0001) or in healthy volunteers (5.08 ± 0.52 mm; P < 0.0001). There was a significant relationship between ONSD and ICP (r = 0.71, P < 0.0001). Enlarged ONSD was a robust predictor of raised ICP (area under the receiver operating characteristic curve = 0.94), with a best cut-off of 5.82 mm, corresponding to a negative predictive value of 92%, and to a value of 100% when ONSD was less than 5.30 mm.
When brain MRI is indicated, ONSD measurement on images obtained using routine sequences can provide a quantitative estimate of the likelihood of significant intracranial hypertension.
Raised intracranial pressure (ICP) is frequent in conditions such as stroke, liver failure, meningitis, meningoencephalitis and postresuscitation syndrome [1–6]. In such diseases, raised ICP may be associated with increased mortality and poor neurological outcomes as a result of ischaemic insults to the brain [4, 7]. Early detection and treatment of raised ICP is therefore critical but often challenging, because invasive ICP monitoring is not routinely undertaken in these settings. However, magnetic resonance imaging (MRI) is often undertaken in such patients, and may provide a noninvasive method of estimating ICP. The optic nerve, as a part of the central nervous system, is surrounded by a subarachnoid space and experiences the same pressure changes as the intracranial compartment [8–11]. The intraorbital part of the sheath, and particularly its retrobulbar segment, can distend when ICP (and hence cerebrospinal fluid [CSF] pressure) is elevated. MRI can be used to measure precisely the diameter optic nerve and its surrounding sheath, by using a fat-suppressed T2-weighted sequence [12, 13]. In cases of idiopathic intracranial hypertension or papilloedema, the retrobulbar optic nerve sheath diameter (ONSD), measured using MRI, has been reported to be enlarged . Moreover, in cases of hypotension in the CSF, ONSD was found to be reduced . However, the precise correlation between MRI-determined ONSD and invasive ICP, which remains the 'gold standard' for ICP measurement, has never been studied. Such a comparison is essential to calibrate the MRI estimation of ICP and to define thresholds for diagnosing intracranial hypertension.
In our institution, brain MRI studies are performed for research purposes during the acute phase of traumatic brain injury (TBI), with a substantial proportion performed in sedated and mechanically ventilated patients with invasive ICP monitoring. We therefore undertook a retrospective analysis of MRI scans in a cohort of TBI patients with ICP monitoring in order to study the relationship between ONSD and ICP and to assess the diagnosis accuracy of ONSD for the detection of raised ICP. MRI scans obtained from healthy volunteers were also studied to define normal values for optic nerve and ONSD.
Materials and methods
This study was a retrospective analysis of data collected prospectively between October 2006 and April 2008 from severe TBI patients with postresuscitation Glasgow Coma Scale score of 8 or less, who required sedation, mechanical ventilation and ICP monitoring. All patients were treated with protocol driven therapy aimed to maintain ICP below 20 mm Hg and cerebral perfusion pressure between 60 and 70 mmHg . Patients were sedated using intravenous propofol and fentanyl, and were mechanically ventilated. Patients were eligible for inclusion if they had undergone MRI, including a T2-weighted sequence, within 1 week of injury. Injury Severity Score and Simplified Acute Physiology Score II were calculated from values obtained at day 1 after patient arrival [17, 18]. Next of kin assent was obtained in all cases. Ethical approval was obtained from the local research ethics committee. Age-matched control individuals (healthy volunteers recruited from the local community by advertisement) who underwent an identical imaging protocol during the same period were also studied. Exclusion criteria for healthy volunteers included a history of psychiatric or physical illness (particularly cardiovascular or neurological disorders), head injury and any history of drug or alcohol dependence, as well as contraindications for MRI.
ICP was continuously measured in TBI patients via an intraparenchymal probe (Codman & Shurlett Inc., Ryanham, MA, USA) inserted into the frontal lobe via Technicam Cranial Access® device (Technicam Ltd, Newton Abbot, UK) by a neurosurgeon. During MRI, the ICP transducer and excess wire were located outside the receive head coil, as has previously been described to be safe and not to cause heating . ICP was continuously monitored during MRI, and readings were collected on a monitoring chart every 10 minutes. The ICP value corresponding to the exact time of acquisition of the T2-weighted MRI sequence was recorded. Raised ICP was defined as ICP above 20 mmHg.
MRI in all individuals was performed using a 3T Magnetom Total Imaging Matrix Trio (Siemens Medical Solutions, Munich, Germany). The axial proton density/T2-weighted turbo spin-echo fat-suppressed sequence was used to measure ONSD and optic nerve diameter (OND). The scan parameters were as follows: repetition time 4,600 ms, echo time 12 ms, pixel bandwidth 185 Hz/pixel, slice thickness 4 mm, spacing between slices 5 mm, and number of slices 27. The optic nerve sheath appeared as a high signal surrounding a region of low signal corresponding to the optic nerve (Figure 1). The axial image slice that provided the best view of the ONSD was chosen and the slice was interpolated to 1,000 × 1,333 pixels using Image J 1.38 (National Institutes of Heath, Bethesda, MD, USA). The retrobulbar area was zoomed to 300×, and then ONSD and OND were measured in an axis perpendicular to the optic nerve, 3 mm behind the globe using an electronic caliper. The OND and the ONSD values obtained from both sides were averaged for comparison with ICP measurements.
Computed tomography (CT) classification was determined from the head CT scan obtained on admission. CT findings were classified as described by Marshall and coworkers : diffuse injury (DI) category I corresponds to no visible intracranial damage on CT scan; DI category II corresponds to a midline shift of 0 to 5 mm; DI category III corresponds to absent or compressed cisterns, with a midline shift of 0 to 5 mm; DI category IV corresponds to a midline shift of more than 5 mm; evacuated mass lesion (EML) corresponds to any surgically evacuated lesion; and nonevacuated mass lesion (NEML) corresponds to a high-density or mixed-density lesion more than 25 mm in diameter and not surgically evacuated.
Statistical analyses were conducted using Statview (Statview 5.0 software; SAS Institute Inc., Cary, NC, USA). After assessment for normality, parametric comparisons were performed using two-tailed Student's t-test. Proportions were compared using χ2 test. To evaluate the diagnostic accuracy for raised ICP, receiver operating characteristic (ROC) curves were produced for ONSD and OND using Medcalc 9.1 Software (Frank Schoonjans, Mariakerke, Belgium). Values are expressed as means ± standard deviation otherwise specified, and P values < 0.05 were considered to be statistically significant.
Role of funding sources
The sponsors of this study and the funding sources played no role in the study design, data collection, data analysis, data interpretation, or writing of the report.
Thirty-eight TBI patients were studied. Seven of them had two MRI studies during the acute phase of TBI, resulting in 45 scans with ICP monitoring. ONSD and OND measurements were possible for both sides in 97% in TBI patients (only left-sided measurements were possible in one patiennt). Thirty-seven healthy volunteers were initially studied. One was excluded because of lack of adequate view of both optic nerves. In two other cases, ONSD and OND were only measured on one side. The overall feasibility of measuring ONSD and OND was therefore calculated as 95% (78/82 scans corresponding to 72/75 individuals). Demographic characteristics of the population are presented in Table 1.
Optic nerve sheath and optic nerve diameters
The mean ONSD in the TBI population was 5.72 ± 0.71 mm, ranging from 4.38 to 7.25 mm. The mean ONSD in healthy volunteers was significantly lower (5.08 ± 0.52 mm; P = 0.0001). The ONSD was significantly higher in TBI patients with raised ICP (>20 mmHg; 6.31 ± 0.50 mm, n = 19) than in TBI patients with ICP of ≤ 20 mmHg (5.29 ± 0.48 mm, n = 26; P < 0.0001) and in healthy volunteers (P < 0.0001). ONSD in TBI patients with ICP of ≤ 20 mmHg and in healthy volunteers were not significantly different (P = 0.12).
The mean OND in the TBI population was 2.65 ± 0.28 mm, ranging from 2.12 to 3.27 mm, and was not significantly different from that in healthy volunteers (2.70 ± 0.23 mm; P = 0.26). OND did not differ between the TBI patients with raised ICP (2.74 ± 0.23 mm) and those with normal ICP (2.58 ± 0.29 mm; P = 0.10) and healthy volunteers (P = 0.71).
Relationship between optic nerve sheath diameter, optic nerve diameter and intracranial pressure
The mean ICP in TBI patients was 18.7 ± 5.7 mmHg, ranging from 7 to 34 mmHg. A significant and strong linear relationship was found between ONSD and ICP (r = 0.71, P < 0.0001; Figure 2a). The 95% confidence limit for the prediction of ICP using ONSD was 9 mmHg. A weaker relationship was found between OND and ICP (r = 0.38, P = 0.01; Figure 2b).
Optic nerve sheath diameter to detect raised intracranial pressure
ONSD accurately predicted an ICP greater than 20 mmHg (area under ROC curve = 0.94, 95% confidence interval = 0.86 to 1.01; P = 0.0001; Figure 3). The best cut-off value of ONSD for detecting raised ICP was 5.82 mm, with a sensitivity of 90%, a specificity of 92% and a negative predictive value of 92%. One hundred per cent sensitivity and negative predictive values were achieved for a 5.30 mm ONSD cut-off. However, OND did not accurately predict raised ICP (area under ROC curve = 0.68, 95% confidence interval = 0.53 to 0.84; P = 0.05). These two ROC curves were significantly different (P = 0.001).
The inter-observer variability in OND and ONSD measurement was assessed by comparing measurements of ONSD and OND in TBI and healthy volunteers. The observers (TG and VN) were blinded to each other's findings, to ICP and to subjects' identity. The inter-observer variability was tested on 23 randomly selected MRI datasets, corresponding to 22 individuals (12 healthy volunteers and 10 TBI patients). The mean standard deviation for ONSD was 0.17 mm, and the mean difference between observers for ONSD was 0.11 mm (Table 2). The agreement between observers is presented in Figure 4.
This study shows that MRI using ONSD measurement is potentially useful in detecting raised ICP. ONSD (but not OND) is strongly related to ICP, a finding that reflects distension of the nerve sheath during increases in CSF pressure. The negative predictive value of an ONSD under 5.82 mm for having ICP above 20 mmHg is more than 90%.
The early detection of raised ICP can be very difficult when invasive devices are not available. Clinical signs of raised ICP such as headache, vomiting and drowsiness are not specific and often difficult to interpret. In sedated patients, clinical signs of raised ICP frequently appear late, when ischaemic brain injury is already established . Furthermore, a normal CT scan does not exclude a raised ICP [22–24].
Fundoscopic evidence of papilloedema can provide useful evidence of intracranial hypertension in cases of chronic raised ICP . However, experimental studies clearly show that oedema of the optic disk requires a few days to develop and resolve, making it a less useful clinical sign in settings where there may be acute increases or dynamic changes in ICP . However, papilloedama is a delayed consequence of chronic CSF accumulation in the retrobulbar optic nerve dural sheath due to raised pressure in CSF in cranial cavity, and direct measurement of such CSF accumulation may provide an earlier and more responsive measure of intracranial hypertension. Optic nerve sheath distension could therefore be an earlier, more reactive and more sensitive sign of raised ICP.
High-resolution MRI is accurate at measuring ONSD [27, 28] and has been proposed to detect raised ICP in idiopathic hydrocephalus and to diagnose shunt malfunction [12, 14, 29, 30]. On T2-weighted sequences, water (and CSF) exhibits a high signal (white). Fat and grey matter appear as light grey, and white matter as dark grey. The perioptic CSF is surrounded by orbital fat. Contrast between CSF and orbital fat can be improved with fat suppression, increasing the image resolution for the ONSD measurement [12, 13]. We have confirmed the utility of this approach, and we provide – for the first time – a quantitative estimate of the relationship between MRI-determined ONSD and ICP. Perhaps more importantly, our data also provide predictive thresholds that enable the exclusion of significant intracranial hypertension. In this context, MRI-derived measurement of ONSD has a low inter-observer variability (less than 0.2 mm), which is substantially less than the mean difference in the measurement between raised ICP and normal ICP patients (1.02 mm) and healthy volunteers (1.23 mm). As a screening test, the technique has a high sensitivity and negative predictive value. For an ONSD cut-off of 5.82 mm, the sensitivity and negative predictive value were 90% and 92%, respectively. A lower cut-off of 5.30 mm resulted in a sensitivity and negative predictive value of 100% for a diagnosis of significant intracranial hypertension, but at the cost of a reduction in specificity to 50%. The most useful clinical message derived from our data may be the following thresholds; an ONSD less than 5.30 mm is unlikely to be associated with raised ICP, and an ONSD above 5.82 mm indicates that the probability of raised ICP is 90%. However, OND had a weaker positive relationship with ICP. Therefore, the increase in ONSD during raised ICP cannot be related only to optic nerve dilatation (as during optic nerve oedema) but also, and predominantly, to its optic nerve sheath distension, probably caused by increased CSF pressure around the optic nerve.
In the present study, TBI patients have significantly greater weights than healthy volunteers (P = 0.0003). Because optic nerve diameters may be related to body size, this could induce a significant bias. However, body weights in TBI patients with raised ICP (n = 14) were not significantly different from those without raised ICP (n = 24; respectively, 89.0 ± 15.8 kg and 84.1 ± 12.6 kg; P = 0.3). The differences observed in ONSD between TBI patients with and without raised ICP can therefore not be attributed to differences in body weight.
A major limitation of this study is probably related to MRI by itself, with limited access, necessity of patient transfer in a magnetic area and specific contraindications. Moreover, in the present study, the slice thickness and interslice spacing were relatively large (4 and 5 mm, respectively). The optic nerve and its sheath were therefore apparent in only one or two slices of the T2-weighted turbo spin-echo sequence. MRI protocols using thinner slices or three-dimensional volumetric acquisition could probably increase the precision of the measurement of ONSD. Consequently, this test should not be used to predict the exact value of ICP but to estimate the probability of intracranial hypertension.
Developing a reliable measurement of ONSD is of interest. In humans, noninvasive assessment of ICP using ocular sonography and ONSD measurement has been proposed in cases of hydrocephalus, hepatic failure and TBI [8, 10, 31–36]. Interestingly, the best cut-off value for raised ICP using ocular sonography was 5.7 to 5.8 mm, which is very close to the figure identified in the present study (5.8 mm). This study corroborates findings obtained with ocular sonography and provides evidence for the use of ONSD measurement when brain MRI is performed in situations that potentially can lead to raised ICP. Proton density/T2-weighted turbo spin-echo is a conventional sequence, lasting less than 3 minutes, which forms part of most routine clinical MRI studies. ONSD measurement could provide important clinical information on the likelihood of intracranial hypertension, and it may help to identify those patients who require more invasive monitoring.
In sedated TBI patients, ONSD measured using conventional brain T2-weighted MRI strongly correlates with invasive ICP. An ONSD above 5.82 mm is associated with a 90% probability of significant intracranial hypertension, whereas the probability of not having significant intracranial hypertension is 90% if the ONSD is under 5.82 mm and 100% if it is less than 5.30 mm. When MRI is indicated, ONSD can easily be measured on routine sequences, and provides a quantitative estimate of the likelihood of significant intracranial hypertension.
The dural sheath surrounding the optic nerve communicates with the subarachnoid space and distends when intracranial pressure is elevated.
MRI can be used to precisely measure the diameter of optic nerve and its sheath.
The ONSD is significantly greater in TBI patients with raised ICP (>20 mmHg) than in those with ICP ≤ 20 mmHg or healthy volunteers. Enlarged ONSD is a robust predictor of raised ICP (area under ROC curve = 0.94).
An ONSD less than 5.30 mm is unlikely to be associated with raised ICP, and an ONSD above 5.82 mm is associated with a 90% probability of raised ICP.
MRI-derived measurement of ONSD has low inter-observer variability.
magnetic resonance imaging
optic nerve diameter
optic nerve sheath diameter
receiver operating characteristic
traumatic brain injury.
Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, Amelink GJ, Schmiedeck P, Schwab S, Rothwell PM, Bousser MG, Worp HB, Hacke W, DECIMAL, DESTINY, and HAMLET investigators: Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007, 6: 215-222. 10.1016/S1474-4422(07)70036-4
Ware AJ, D'Agostino AN, Combes B: Cerebral edema: a major complication of massive hepatic necrosis. Gastroenterology 1971, 61: 877-884.
Quagliarello V, Scheld WM: Bacterial meningitis: pathogenesis, pathophysiology, and progress. N Engl J Med 1992, 327: 864-872.
Newton CR, Crawley J, Sowumni A, Waruiru C, Mwangi I, English M, Murphy S, Winstanley PA, Marsh K, Kirkham FJ: Intracranial hypertension in Africans with cerebral malaria. Arch Dis Child 1997, 76: 219-226.
Pedersen M, Brandt CT, Knudsen GM, Ostergaard C, Skinhoj P, Frimodt-Moller N, Moller K: Cerebral blood flow autoregulation in early experimental S. pneumoniae meningitis. J Appl Physiol 2007, 102: 72-78. 10.1152/japplphysiol.00697.2006
Bergman R, Tjan DH, Adriaanse MW, van Vugt R, van Zanten AR: Unexpected fatal neurological deterioration after sucessful cardio-pulmonary resuscitation and therapeutic hypothermia. Resuscitation 2008, 76: 142-145. 10.1016/j.resuscitation.2007.06.011
Calvo A, Hernandez P, Spagnuolo E, Johnston E: Surgical treatment of intracranial hypertension in encephalic cryptococcosis. Br J Neurosurg 2003, 17: 450-455. 10.1080/02688690310001611242
Hansen HC, Helmke K: The subarachnoid space surrounding the optic nerves. An ultrasound study of the optic nerve sheath. Surg Radiol Anat 1996, 18: 323-328. 10.1007/BF01627611
Helmke K, Hansen HC: Fundamentals of transorbital sonographic evaluation of optic nerve sheath expansion under intracranial hypertension. I. Experimental study. Pediatr Radiol 1996, 26: 701-705. 10.1007/BF01383383
Helmke K, Hansen HC: Fundamentals of transorbital sonographic evaluation of optic nerve sheath expansion under intracranial hypertension II. Patient study. Pediatr Radiol 1996, 26: 706-710. 10.1007/BF01383384
Hansen HC, Helmke K: Validation of the optic nerve sheath response to changing cerebrospinal fluid pressure: ultrasound findings during intrathecal infusion tests. J Neurosurg 1997, 87: 34-40.
Mashima Y, Oshitari K, Imamura Y, Momoshima S, Shiga H, Oguchi Y: High-resolution magnetic resonance imaging of the intraorbital optic nerve and subarachnoid space in patients with papilledema and optic atrophy. Arch Ophthalmol 1996, 114: 1197-1203.
Lam BL, Glasier CM, Feuer WJ: Subarachnoid fluid of the optic nerve in normal adults. Ophthalmology 1997, 104: 1629-1633.
Gass A, Barker GJ, Riordan-Eva P, MacManus D, Sanders M, Tofts PS, McDonald WI, Moseley IF, Miller DH: MRI of the optic nerve in benign intracranial hypertension. Neuroradiology 1996, 38: 769-773. 10.1007/s002340050344
Watanabe A, Horikoshi T, Uchida M, Ishigame K, Kinouchi H: Decreased diameter of the optic nerve sheath associated with CSF hypovolemia. AJNR Am J Neuroradiol 2008, 29: 863-864. 10.3174/ajnr.A1027
Menon DK: Cerebral protection in severe brain injury: physiological determinants of outcome and their optimisation. Br Med Bull 1999, 55: 226-258. 10.1258/0007142991902231
Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270: 2957-2963. 10.1001/jama.270.24.2957
Civil ID, Schwab CW: The Abbreviated Injury Scale, 1985 revision: a condensed chart for clinical use. J Trauma 1988, 28: 87-90.
Newcombe VF, Hawkes RC, Harding SG, Wilcox R, Brock S, Hutchinson P, Menon DK, Carpenter TA, Coles JP: Potential heating caused by intraparenchymal intracranial pressure transducers in a 3-tesla magnetic resonance imaging system using a body radiofrequency resonator: assessment of the Codman MicroSensor Transducer. J Neurosurg 2008, 109: 159-64. 10.3171/JNS/2008/109/7/0159
Marshall LF, Marshall SB, Klauber MR, Van Berkum Clark M, Eisenberg H, Jane JA, Luerssen TG, Marmarou A, Foulkes MA: The diagnosis of head injury requires a classification based on computed axial tomography. J Neurotrauma 1992,9(suppl 1):S287-S292.
Ghajar J: Traumatic brain injury. Lancet 2000, 356: 923-929. 10.1016/S0140-6736(00)02689-1
O'Sullivan MG, Statham PF, Jones PA, Miller JD, Dearden NM, Piper IR, Anderson SI, Housley A, Andrews PJ, Midgley S, et al.: Role of intracranial pressure monitoring in severely head-injured patients without signs of intracranial hypertension on initial computerized tomography. J Neurosurg 1994, 80: 46-50.
Winkler F, Kastenbauer S, Yousry TA, Maerz U, Pfister HW: Discrepancies between brain CT imaging and severely raised intracranial pressure proven by ventriculostomy in adults with pneumococcal meningitis. J Neurol 2002, 249: 1292-1297. 10.1007/s00415-002-0844-8
Hiler M, Czosnyka M, Hutchinson P, Balestreri M, Smielewski P, Matta B, Pickard JD: Predictive value of initial computerized tomography scan, intracranial pressure, and state of autoregulation in patients with traumatic brain injury. J Neurosurg 2006, 104: 731-737. 10.3171/jns.2006.104.5.731
Friedman DI, Jacobson DM: Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002, 59: 1492-1495. 10.1001/archneur.59.9.1492
Hayreh SS: Pathogenesis of oedema of the optic disc (papilloedema). A preliminary report. Br J Ophthalmol 1964, 48: 522-543. 10.1136/bjo.48.10.522
Ozgen A, Aydingoz U: Normative measurements of orbital structures using MRI. J Comput Assist Tomogr 2000, 24: 493-496. 10.1097/00004728-200005000-00025
Weigel M, Lagreze WA, Lazzaro A, Hennig J, Bley TA: Fast and quantitative high-resolution magnetic resonance imaging of the optic nerve at 3.0 tesla. Invest Radiol 2006, 41: 83-86. 10.1097/01.rli.0000195820.98062.c5
Brodsky MC, Vaphiades M: Magnetic resonance imaging in pseudotumor cerebri. Ophthalmology 1998, 105: 1686-1693. 10.1016/S0161-6420(98)99039-X
Agid R, Farb RI, Willinsky RA, Mikulis DJ, Tomlinson G: Idiopathic intracranial hypertension: the validity of cross-sectional neuroimaging signs. Neuroradiology 2006, 48: 521-527. 10.1007/s00234-006-0095-y
Helmke K, Burdelski M, Hansen HC: Detection and monitoring of intracranial pressure dysregulation in liver failure by ultrasound. Transplantation 2000, 70: 392-395. 10.1097/00007890-200007270-00029
Geeraerts T, Launey Y, Martin L, Pottecher J, Vigue B, Duranteau J, Benhamou D: Ultrasonography of the optic nerve sheath may be useful for detecting raised intracranial pressure after severe brain injury. Intensive Care Med 2007, 33: 1704-1711. 10.1007/s00134-007-0797-6
Blaivas M, Theodoro D, Sierzenski PR: Elevated intracranial pressure detected by bedside emergency ultrasonography of the optic nerve sheath. Acad Emerg Med 2003, 10: 376-381. 10.1111/j.1553-2712.2003.tb01352.x
Geeraerts T, Duranteau J, Benhamou D: Ocular sonography in patients with raised intracranial pressure: the papilloedema revisited. Crit Care 2008, 12: 150. 10.1186/cc6893
Geeraerts T, Merceron S, Benhamou D, Vigue B, Duranteau J: Non-invasive assessment of intracranial pressure using ocular sonography in neurocritical care patients. Intensive Care Med 2008, in press.
Soldatos T, Karakitsos D, Chatzimichail K, Papathanasiou M, Gouliamos A, Karabinis A: Optic nerve sonography in the diagnostic evaluation of adult brain injury. Crit Care 2008, 12: R67. 10.1186/cc6897
Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1: 307-310.
This research was conducted within the frameworks of a Medical Research Council (UK) Program Grant (Acute brain injury: heterogeneity of mechanisms, therapeutic targets and outcome effects [G9439390 ID 65883]) and of the Biomedical Research Center, Addenbrooke's Hospital, Cambridge, UK.
TG is supported by grants from the Société Française d'Anesthésie et de Réanimation (SFAR) and from Journées d'Enseignement Post-Universitaire d'Anesthésie-Réanimation (JEPU)-Novo Nordisk. VFJN is supported by the Gates Cambridge Trust and an Overseas Research Studentship. JPC is supported by an Academy of Medical Sciences/Health Foundation Clinician Scientist Fellowship (UK). PJAH is supported by an Academy of Medical Science/Health Foundation Senior Surgical Scientist Fellowship (UK). DKM is supported by grants from the Medical Research Council (UK), Royal College of Anaesthetists, Wellcome Trust, the Evelyn Trust, and Queens' College Cambridge.
The authors declare that they have no competing interests.
TG conceived of the study, collected data, performed statistical analysis and drafted the manuscript. VFJN collected data and helped to perform statistical analysis and draft the manuscript. JPC participated in study design and helped to draft the manuscript. MGA, IEP, JGO and DAC helped to collect data. PJAH helped to draft the manuscript. DKM participated in the study design and coordination, and helped to draft the manuscript. All authors read and approved the final manuscript.
About this article
Cite this article
Geeraerts, T., Newcombe, V.F., Coles, J.P. et al. Use of T2-weighted magnetic resonance imaging of the optic nerve sheath to detect raised intracranial pressure. Crit Care 12, R114 (2008). https://doi.org/10.1186/cc7006
- Traumatic Brain Injury
- Optic Nerve
- Intracranial Hypertension
- Traumatic Brain Injury Patient
- Idiopathic Intracranial Hypertension